Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Completed · Phase 2
Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving docetaxel together with carboplatin works in treating patients with ovarian epithelial, fallopian tube, or peritoneal cavity cancer.
Key facts
- Study ID
- NCT00138242
- Run by
- Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center
- People needed
- 30
- Starts
- 2004-12-01
- Expected to finish
- 2006-10-01
- Last updated by the study team
- 2013-06-26
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.